David Bower and Agata Wiśniowska discuss how addressing payer needs in the product development process can help companies increase patient access to their novel treatments.
David Bower, Agata Wiśniowska
Advertisement
David Bower is a Global Value & Access Lead for DUPIXENT in Dermatology indications at Sanofi Genzyme. Agata Wiśniowska is a senior consultant in Life Sciences at Guidehouse.
Articles by David Bower, Agata Wiśniowska
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
